BioTissue introduced the CAM360 AmnioGraft (CAM360 AG), a hydrated, shelf-stable cryopreserved amniotic membrane (CAM) solution. CAM360 AG is ideal for patients who have mild to moderate dry eye disease and other ocular surface conditions, the company stated in a press release.

CAM360 AG is a ringless CAM that does not require refrigeration, which simplifies storage simple for practices. CAM360 AG's adhesive properties ensure that the CAM stays in place under a bandage contact lens, increasing patient comfort and treatment efficacy while patients go on with their normal daily lives, the company stated.
 
According to the company, BioTissue’s proprietary CryoTek and SteriTek preservation methods retain the HC-HA/PTX3 found in fresh tissue, which is, in part, responsible for amniotic membrane’s therapeutic benefits. These processes were specifically designed to optimize preservation while providing efficiencies in handling, storage and product application.
 
BioTissue said it has begun initial shipments of the product, with nationwide availability expected by the end of the month.